Exogenous Pathogen and Plant 15-Lipoxygenase Initiate Endogenous Lipoxin A4 Biosynthesis

Lipoxin A4 (LXA4) is a potent endogenous lipoxygenase-derived eicosanoid with antiinflammatory and proresolving properties. Supraphysiological levels of LXA4 are generated during infection by Toxoplasma gondii, which in turn reduces interleukin (IL) 12 production by dendritic cells, thus dampening Th1-type cell-mediated immune responses and host immunopathology. In the present work, we sought evidence for the structural basis of T. gondii's ability to activate LXA4 biosynthesis. Proteomic analysis of T. gondii extract (soluble tachyzoite antigen [STAg]), which preserves the immunosuppressive and antiinflammatory activity of the parasite, yielded several peptide matches to known plant lipoxygenases. Hence, we incubated STAg itself with arachidonic acid and found using LC-UV-MS-MS–based lipidomics that STAg produced both 15-HETE and 5,15-diHETE, indicating that T. gondii carries 15-lipoxygenase activity. In addition, T. gondii tachyzoites (the rapidly multiplying and invasive stage of the parasite) generated LXA4 when provided with arachidonic acid. Local administration of a plant (soybean) lipoxygenase itself reduced neutrophilic infiltration in murine peritonitis, demonstrating that 15-lipoxygenase possesses antiinflammatory properties. Administration of plant 15-lipoxygenase generated endogenous LXA4 and mimicked the suppression of IL-12 production by splenic dendritic cells observed after T. gondii infection or STAg administration. Together, these results indicate that 15-lipoxygenase expressed by a pathogen as well as exogenously administered 15-lipoxygenase can interact with host biosynthetic circuits for endogenous “stop signals” that divert the host immune response and limit acute inflammation.

[1]  C. Serhan,et al.  Aspirin-Triggered Lipoxin A4 and B4 Analogs Block Extracellular Signal-Regulated Kinase-Dependent TNF-α Secretion from Human T Cells 1 , 2003, The Journal of Immunology.

[2]  H. Sies,et al.  Inhibition of 15-lipoxygenases by flavonoids: structure-activity relations and mode of action. , 2003, Biochemical pharmacology.

[3]  Jessica C Kissinger,et al.  Gene discovery in the apicomplexa as revealed by EST sequencing and assembly of a comparative gene database. , 2003, Genome research.

[4]  Carl Nathan,et al.  Points of control in inflammation , 2002, Nature.

[5]  C. Serhan.  Endogenous Chemical Mediators in Anti-Inflammation and Pro-Resolution , 2002 .

[6]  A. Sher,et al.  Parasite-induced Lipoxin A4 Is an Endogenous Regulator of IL-12 Production and Immunopathology in Toxoplasma gondii Infection , 2002, The Journal of experimental medicine.

[7]  Simon J Hubbard,et al.  Comparative bioinformatic analysis of complete proteomes and protein parameters for cross‐species identification in proteomics , 2002, Proteomics.

[8]  A. Sher,et al.  Lipoxin-mediated inhibition of IL-12 production by DCs: a mechanism for regulation of microbial immunity , 2002, Nature Immunology.

[9]  P. Macmathuna,et al.  Lipoxin A4 and Aspirin-Triggered 15-Epi-Lipoxin A4 Antagonize TNF-α-Stimulated Neutrophil-Enterocyte Interactions In Vitro and Attenuate TNF-α-Induced Chemokine Release and Colonocyte Apoptosis in Human Intestinal Mucosa Ex Vivo1 , 2001, The Journal of Immunology.

[10]  Charles N. Serhan,et al.  Lipid mediator class switching during acute inflammation: signals in resolution , 2001, Nature Immunology.

[11]  M. Mortuaire,et al.  Differential expression of two plant-like enolases with distinct enzymatic and antigenic properties during stage conversion of the protozoan parasite Toxoplasma gondii. , 2001, Journal of molecular biology.

[12]  T. Rajan,et al.  INHIBITORS OF THE LIPOXYGENASE PATHWAY BLOCK DEVELOPMENT OF BRUGIA MALAYI L3 IN VITRO , 2001, The Journal of parasitology.

[13]  T. Horii,et al.  Identification of a Novel Prostaglandin F2α Synthase in Trypanosoma brucei , 2000, The Journal of experimental medicine.

[14]  A. Sher,et al.  CD40 triggering of heterodimeric IL-12 p70 production by dendritic cells in vivo requires a microbial priming signal. , 2000, Immunity.

[15]  A. Sher,et al.  CCR5 provides a signal for microbial induced production of IL-12 by CD8α+ dendritic cells , 2000, Nature Immunology.

[16]  C. Serhan,et al.  Cutting Edge: Lipoxin (LX) A4 and Aspirin-Triggered 15-Epi-LXA4 Block Allergen-Induced Eosinophil Trafficking1 , 2000, The Journal of Immunology.

[17]  A. Sher,et al.  CCR5 provides a signal for microbial induced production of IL-12 by CD8 alpha+ dendritic cells. , 2000, Nature immunology.

[18]  H. Kuhn.  Structural basis for the positional specificity of lipoxygenases. , 2000, Prostaglandins & other lipid mediators.

[19]  A. Sher,et al.  Paralysis of dendritic cell IL-12 production by microbial products prevents infection-induced immunopathology. , 1999, Immunity.

[20]  C. Clish,et al.  Aspirin-triggered 15-epi-lipoxin A4 (ATL) generation by human leukocytes and murine peritonitis exudates: development of a specific 15-epi-LXA4 ELISA. , 1998, The Journal of pharmacology and experimental therapeutics.

[21]  M. Wilkins,et al.  Cross-species protein identification using amino acid composition, peptide mass fingerprinting, isoelectric point and molecular mass: a theoretical evaluation. , 1997, Journal of theoretical biology.

[22]  J. Palmer,et al.  A Plastid of Probable Green Algal Origin in Apicomplexan Parasites , 1997, Science.

[23]  A. Sher,et al.  Biochemical characterization and protein kinase C dependency of monokine-inducing activities of Toxoplasma gondii , 1996, Infection and immunity.

[24]  C. Serhan.  Lipoxin biosynthesis and its impact in inflammatory and vascular events. , 1994, Biochimica et biophysica acta.

[25]  S. Yamamoto,et al.  Lipoxin synthase activity of human platelet 12-lipoxygenase. , 1993, The Biochemical journal.

[26]  C. Serhan.  Cell-cell interactions in the generation of eicosanoids: charting the routes and products of transcellular biosynthesis. , 1993, The Journal of laboratory and clinical medicine.

[27]  P. Borgeat,et al.  Transcellular metabolism of arachidonic acid in platelets and polymorphonuclear leukocytes activated by physiological agonists: enhancement of leukotriene B4 synthesis. , 1991, Advances in experimental medicine and biology.

[28]  K. M. Madyastha,et al.  Biological Oxidation Systems , 1990 .

[29]  C. Serhan,et al.  Intravascular filarial parasites elaborate cyclooxygenase-derived eicosanoids , 1990, The Journal of experimental medicine.

[30]  C. Serhan,et al.  Lipoxin formation during human neutrophil-platelet interactions. Evidence for the transformation of leukotriene A4 by platelet 12-lipoxygenase in vitro. , 1990, The Journal of clinical investigation.

[31]  S. Dahlén,et al.  Leukotrienes and lipoxins: structures, biosynthesis, and biological effects. , 1987, Science.

[32]  C. Serhan,et al.  Action of novel eicosanoids lipoxin A and B on human natural killer cell cytotoxicity: effects on intracellular cAMP and target cell binding. , 1985, Journal of immunology.

[33]  W. Henderson,et al.  Alteration of leukotriene release by macrophages ingesting Toxoplasma gondii. , 1985, Proceedings of the National Academy of Sciences of the United States of America.

[34]  A. Fusco,et al.  Schistosoma mansoni: eicosanoid production by cercariae. , 1985, Experimental parasitology.

[35]  J. Vliegenthart,et al.  Double dioxygenation of arachidonic acid by soybean lipoxygenase-1. Kinetics and regio-stereo specificities of the reaction steps. , 1981, Biochimica et biophysica acta.

[36]  C. S. Ramadoss,et al.  Double dioxygenation of arachidonic acid by soybean lipoxygenase--1. , 1977, Biochemical and biophysical research communications.

[37]  W. P. Callahan,et al.  A CLINICOPATHOLOGIC STUDY WITH PRESENTATION OF FIVE CASES AND REVIEW OF THE LITERATURE , 1946 .

[38]  W. P. Callahan,et al.  Human toxoplasmosis; a clinicopathologic study with presentation of five cases and review of the literature. , 1946, Medicine.